Inozyme Pharma, Inc. Announces Proposed Offering of Common

BOSTON, July 27, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel...

Related Keywords

Boston ,Massachusetts ,United States ,Minnesota ,New York ,Matt Pera ,Stefan Riley ,Inozyme Pharma ,Piper Sandler ,Corporate Communications ,Prospectus Department ,Nasdaq ,Exchange Commission ,Inozyme Pharma Inc ,Bofa Securities ,Tryon Street ,Private Securities Litigation Reform Act ,Nasdaq Inzy ,Nozyme Pharma Inc ,